- Home
- MTEK vs OSRH Comparison
MTEK vs OSRH Comparison
Compare MTEK & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEK
- OSRH
- Stock Information
- Founded
- MTEK 2008
- OSRH N/A
- Country
- MTEK Israel
- OSRH United States
- Employees
- MTEK N/A
- OSRH N/A
- Industry
- MTEK
- OSRH
- Sector
- MTEK
- OSRH
- Exchange
- MTEK Nasdaq
- OSRH Nasdaq
- Market Cap
- MTEK 15.1M
- OSRH 13.2M
- IPO Year
- MTEK 2022
- OSRH N/A
- Fundamental
- Price
- MTEK $1.33
- OSRH $0.60
- Analyst Decision
- MTEK
- OSRH
- Analyst Count
- MTEK 0
- OSRH 0
- Target Price
- MTEK N/A
- OSRH N/A
- AVG Volume (30 Days)
- MTEK 67.6K
- OSRH 3.4M
- Earning Date
- MTEK 09-26-2025
- OSRH 11-24-2025
- Dividend Yield
- MTEK N/A
- OSRH N/A
- EPS Growth
- MTEK N/A
- OSRH N/A
- EPS
- MTEK N/A
- OSRH N/A
- Revenue
- MTEK $3,375,716.00
- OSRH $104,735.00
- Revenue This Year
- MTEK N/A
- OSRH N/A
- Revenue Next Year
- MTEK N/A
- OSRH N/A
- P/E Ratio
- MTEK N/A
- OSRH N/A
- Revenue Growth
- MTEK N/A
- OSRH N/A
- 52 Week Low
- MTEK $1.31
- OSRH $0.45
- 52 Week High
- MTEK $6.47
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- MTEK 28.07
- OSRH 46.12
- Support Level
- MTEK $1.63
- OSRH $0.59
- Resistance Level
- MTEK $1.80
- OSRH $0.74
- Average True Range (ATR)
- MTEK 0.14
- OSRH 0.09
- MACD
- MTEK -0.01
- OSRH -0.00
- Stochastic Oscillator
- MTEK 6.22
- OSRH 17.47
About MTEK Maris-Tech Ltd.
Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.